Results 101 to 110 of about 38,526 (184)

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3. [PDF]

EJHaem
Qu F, Hui M, Yang F, Huang B, Liu N, He Y, Wang X.   +6 more
europepmc   +1 more source

Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines. [PDF]

J Cell Mol Med
Okabe S, Yoshizawa S, Arai Y, Gotoh A, Akahane D.   +4 more
europepmc   +1 more source

A case of a digitate injection site reaction from subcutaneous bortezomib in a patient with myeloma. [PDF]

SAGE Open Med Case Rep
Creighton R, Eglington T, Chen LYC, Sutherland AE.   +3 more
europepmc   +1 more source

Pharmacovigilance study on neurological adverse reactions of proteasome inhibitors in the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li S, Ling T, Liu Y, Li J.
europepmc   +1 more source

Depletion of IgG-producing plasma cells in the colon by treatment of proteasome inhibitor ameliorates chronic DSS-induced colitis in mice. [PDF]

Sci Rep
Ebihara S, Kimoto Y, Katsumoto R, Konishi N.   +3 more
europepmc   +1 more source

Kinetics of MM1.S Multiple Myeloma Cells in a 3D Polymer Particle Culture System with Bone Marrow Stromal Cells and Bortezomib. [PDF]

Pharmaceuticals (Basel)
Aizawa S, Yuda M, Hirai S, Tsuboi I, Koike T, Hatta Y, Miura K, Yasuda M.   +7 more
europepmc   +1 more source

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]

Hematol Rep
Peláez Casillas N, Verdaguer Muñoz JM, Rodríguez Valiente A, Romera Martínez I, García Berrocal JR.   +4 more
europepmc   +1 more source

Wogonin derivative V8 enhances bortezomib efficacy in gastric carcinoma by disrupting lysosome-mediated drug resistance. [PDF]

World J Gastroenterol
Li SC, Shao SZ, Zhang YH, Zhou Y, Shang WT, Gao Y, He QB, Guo QL, Guo CY, Zhang XB.   +9 more
europepmc   +1 more source

Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies. [PDF]

Front Oncol
Cavo M, Bringhen S, Buda G, Di Raimondo F, Musto P, Offidani M, Petrucci MT, Zamagni E, Zambello R, Berruto F, Freddi R, La Malfa P.   +11 more
europepmc   +1 more source

Atypical presentation of DRESS/DiHS mimicking an acquired ichthyosis: A case report of bortezomib-induced severe erythroderma in multiple myeloma. [PDF]

SAGE Open Med Case Rep
Lu C, Belmesk L, Bélisle A, Masse MS, Ouellette S, Cote B.   +5 more
europepmc   +1 more source